<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/88077807-2572-4B6D-8467-0822C6A212BD"><gtr:id>88077807-2572-4B6D-8467-0822C6A212BD</gtr:id><gtr:name>NHS Blood and Transplant (NHSBT)</gtr:name><gtr:address><gtr:line1>Oak House
Reeds Crescent</gtr:line1><gtr:city>Watford</gtr:city><gtr:postCode>WD24 4QN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/88077807-2572-4B6D-8467-0822C6A212BD"><gtr:id>88077807-2572-4B6D-8467-0822C6A212BD</gtr:id><gtr:name>NHS Blood and Transplant (NHSBT)</gtr:name><gtr:address><gtr:line1>Oak House
Reeds Crescent</gtr:line1><gtr:city>Watford</gtr:city><gtr:postCode>WD24 4QN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6A64A971-7ECF-46CD-A9F3-4550D516D7C4"><gtr:id>6A64A971-7ECF-46CD-A9F3-4550D516D7C4</gtr:id><gtr:firstName>Susan</gtr:firstName><gtr:surname>Barnes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9D4ED459-1A3C-4EDD-8EFD-AECE9355C90A"><gtr:id>9D4ED459-1A3C-4EDD-8EFD-AECE9355C90A</gtr:id><gtr:firstName>Adam</gtr:firstName><gtr:surname>Timmis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/912B3A83-CD26-4E43-B5A4-5098DFB16330"><gtr:id>912B3A83-CD26-4E43-B5A4-5098DFB16330</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:surname>Cohn</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A02E3B12-AD37-43C4-A76C-5B5C1FD42257"><gtr:id>A02E3B12-AD37-43C4-A76C-5B5C1FD42257</gtr:id><gtr:firstName>Willem</gtr:firstName><gtr:surname>Ouwehand</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/01A2B752-F82F-4F2F-B246-458D6E5D872D"><gtr:id>01A2B752-F82F-4F2F-B246-458D6E5D872D</gtr:id><gtr:firstName>Harry</gtr:firstName><gtr:surname>Hemingway</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4B98F259-77FE-4FC0-9296-140C9C066977"><gtr:id>4B98F259-77FE-4FC0-9296-140C9C066977</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Danesh</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FA6C0C1E-2C5B-4074-BD9E-CBE6F6A557EE"><gtr:id>FA6C0C1E-2C5B-4074-BD9E-CBE6F6A557EE</gtr:id><gtr:firstName>Kausik</gtr:firstName><gtr:otherNames>Kumar</gtr:otherNames><gtr:surname>Ray</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_qA137933"><gtr:id>27054075-3DF7-44A7-9C4A-0AA5D26B2C78</gtr:id><gtr:title>A pilot study for the establishment of large-scale bioresources by linking blood donor samples with electronic heal</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_qA137933</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Reliable assessment of the interplay of genetic and major lifestyle factors in common diseases requires particularly large studies: for example, study of 0.5M healthy adults in the #60M UK Biobank study should yield 10,000 incident cases of myocardial infarction for analyses after several years of follow-up. The current proposal is for a pilot study to determine the feasibility and acceptability of establishing large bioresources by involving individuals accessing health services for other purposes. IN particular, it is proposed to explore linkage of: (i) millions of blood samples collected through the NHS blood and transplant (NHSBT, formerly the National Blood Service), and (ii) disease outcomes recorded in electronic records, notably the Myocardial Infarction National Audit Project. The proposed pilot study will focus on: (i) the potential impact of health questionnaires, genetic studies and data linkage on blood donation (i.e., assessment of acceptability to blood donors and to the NHSBT), (ii) feasibility of database linkage, and (iii) processing and storage of biological material. In addition to informing decisions about the potential conduct of a large study of blood donors, this pilot study should yield generalisable knowledge about the potential for embedding aspects of population health research into routine health services.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>350307</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>NHS Blood and Transplant (NHSBT)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>INTERVAL</gtr:description><gtr:id>800AD182-B5A0-4F0A-91CB-4B7AA42C2374</gtr:id><gtr:impact>INTERVAL is a randomised controlled trial in up to 50,000 whole-blood donors recruited at 25 locations across England. Participants are involved in a two-year intervention during which they are invited to give blood either at usual donation intervals or more often. The primary aim of the intervention is to establish whether donors can safely and acceptably give blood more often than is now collected by NHS Blood and Transplant. 

A further aim of INTERVAL is to create a national epidemiological bioresource, including a recall-by-genotype (phenotype) resource, which will enable detailed study of the health of blood donors and broader public health and biomedical issues. 

Participant recruitment commenced in June 2012. Our target of 50,000 study participants was reached two years later, in June 2014. Participants have consented to: use of their data and biological samples for a wide range of analyses, invitation to further biomedical studies, and long-term linkage to e-health records. Funding that has been awarded from NHSBT and NIHR will allow the study of the following factors in 50,000 participants i) extended haematological profile (&amp;gt;200 parameters) ii) lifestyle profiling, including assessment of smoking, alcohol consumption, dietary intake, and, in large subsets, monitoring of physical activity through the use of worn accelerometry devices; (iii) cognitive function traits related to different domains of mental function and well-being; and (iv) linkage with e-health records, eg, various morbidity registers, hospital discharge records (v) a novel gene array containing 850,000 single nucleotide variants (SNVs), which includes many functional SNVs and a GWAS scaffold to deliver imputation of ~20 million variants; (vi) ~200 candidate biomarkers related to haematological traits and other pathways for a wide range of disease processes (eg, liver and renal function; autoimmunity; hormonal status).</gtr:impact><gtr:outcomeId>MhqB5TskfPk-1</gtr:outcomeId><gtr:partnerContribution>NHSBT provide funding and operational support.

The University of Oxford provide scientific leadership and operational support.</gtr:partnerContribution><gtr:piContribution>We provide scientific leadership and operational support.

We are the academic coordinating centre, running the administration and data management of the trial (including the helpline).</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>INTERVAL</gtr:description><gtr:id>28B2D108-E68F-4122-AA90-623F7F7B270D</gtr:id><gtr:impact>INTERVAL is a randomised controlled trial in up to 50,000 whole-blood donors recruited at 25 locations across England. Participants are involved in a two-year intervention during which they are invited to give blood either at usual donation intervals or more often. The primary aim of the intervention is to establish whether donors can safely and acceptably give blood more often than is now collected by NHS Blood and Transplant. 

A further aim of INTERVAL is to create a national epidemiological bioresource, including a recall-by-genotype (phenotype) resource, which will enable detailed study of the health of blood donors and broader public health and biomedical issues. 

Participant recruitment commenced in June 2012. Our target of 50,000 study participants was reached two years later, in June 2014. Participants have consented to: use of their data and biological samples for a wide range of analyses, invitation to further biomedical studies, and long-term linkage to e-health records. Funding that has been awarded from NHSBT and NIHR will allow the study of the following factors in 50,000 participants i) extended haematological profile (&amp;gt;200 parameters) ii) lifestyle profiling, including assessment of smoking, alcohol consumption, dietary intake, and, in large subsets, monitoring of physical activity through the use of worn accelerometry devices; (iii) cognitive function traits related to different domains of mental function and well-being; and (iv) linkage with e-health records, eg, various morbidity registers, hospital discharge records (v) a novel gene array containing 850,000 single nucleotide variants (SNVs), which includes many functional SNVs and a GWAS scaffold to deliver imputation of ~20 million variants; (vi) ~200 candidate biomarkers related to haematological traits and other pathways for a wide range of disease processes (eg, liver and renal function; autoimmunity; hormonal status).</gtr:impact><gtr:outcomeId>MhqB5TskfPk-2</gtr:outcomeId><gtr:partnerContribution>NHSBT provide funding and operational support.

The University of Oxford provide scientific leadership and operational support.</gtr:partnerContribution><gtr:piContribution>We provide scientific leadership and operational support.

We are the academic coordinating centre, running the administration and data management of the trial (including the helpline).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>NHSBT R&amp;D conference, Oxford</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CA53DD53-226F-4479-B19D-867742D138F0</gtr:id><gtr:impact>150 people attended the conference including senior NHSBT management

Initiated discussions, with senior NHSBT management, on the potential for future research studies in blood donors</gtr:impact><gtr:outcomeId>NU1CBTosTFd</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>COMPARE is a study of 30,000 English blood donors set up to determine for NHS Blood and Transplant the most effective way of measuring haemaglobin levels in blood donors. Additionally, participants in the study have consented to have the blood samples used in research and data from genetic and biomarker assays and through linkage with electronic health records will be used across a range of research projects.</gtr:description><gtr:id>65594F47-538C-4FD3-9803-E3A5CEDC3F42</gtr:id><gtr:impact>No impact yet, participants still being recruited.</gtr:impact><gtr:outcomeId>58ca94cac348d3.15158942</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>COMPARE</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.comparestudy.org.uk/about-the-study/</gtr:url></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>A database has been built using: demographic data, physical measurements' data (e.g. height, weight, blood pressure), health and lifestyle questionnaire data (e.g. smoking, physical activity, diet, alcohol, family history), attitudinal questionnaire data in relation to acceptability of the research, physical activity data</gtr:description><gtr:id>D3F56FCB-B46A-4DB4-85B3-7D730504013D</gtr:id><gtr:impact>None at present</gtr:impact><gtr:outcomeId>56e122372d70c1.96757225</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Database</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.phpc.cam.ac.uk/ceu/research/cardioresource/</gtr:url><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>INTERVAL is a randomised controlled trial in up to 50,000 whole-blood donors recruited at 25 locations across England. Participants are involved in a two-year intervention during which they are invited to give blood either at usual donation intervals or more often. The primary aim of the intervention is to establish whether donors can safely and acceptably give blood more often than is now collected by NHS Blood and Transplant. 

A further aim of INTERVAL is to create a national epidemiological bioresource, including a recall-by-genotype (phenotype) resource, which will enable detailed study of the health of blood donors and broader public health and biomedical issues. 

Participant recruitment commenced in June 2012. Our target of 50,000 study participants was reached two years later, in June 2014. Participants have consented to: use of their data and biological samples for a wide range of analyses, invitation to further biomedical studies, and long-term linkage to e-health records. Funding that has been awarded from NHSBT and NIHR will allow the study of the following factors in 50,000 participants i) extended haematological profile (&amp;gt;200 parameters) ii) lifestyle profiling, including assessment of smoking, alcohol consumption, dietary intake, and, in large subsets, monitoring of physical activity through the use of worn accelerometry devices; (iii) cognitive function traits related to different domains of mental function and well-being; and (iv) linkage with e-health records, eg, various morbidity registers, hospital discharge records (v) a novel gene array containing 850,000 single nucleotide variants (SNVs), which includes many functional SNVs and a GWAS scaffold to deliver imputation of ~20 million variants; (vi) ~200 candidate biomarkers related to haematological traits and other pathways for a wide range of disease processes (eg, liver and renal function; autoimmunity; hormonal status).</gtr:description><gtr:id>6D8A244E-1B6E-40DF-ABC4-2B10F7B4C9B0</gtr:id><gtr:impact>Serum samples collected during the study have been used to measure the levels of ferritin in participants.

DNA has been used in a genome-wide association study of haemoglobin concentration and related parameters, and genotyping of the HFE gene.</gtr:impact><gtr:outcomeId>Y9BV1WeKjNY</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>INTERVAL Bioresource</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>COMPARE is a study of 30,000 English blood donors set up to determine for NHS Blood and Transplant the most effective way of measuring haemaglobin levels in blood donors. Additionally, participants in the study have consented to have the blood samples used in research and data from genetic and biomarker assays and through linkage with electronic health records will be used across a range of research projects.</gtr:description><gtr:id>056ACC9B-9445-43C6-B547-A054E6F54189</gtr:id><gtr:impact>No impact yet, samples still being collected.</gtr:impact><gtr:outcomeId>58ca93f9ede680.22882541</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>COMPARE</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://www.comparestudy.org.uk/about-the-study/</gtr:url></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>4D0E787F-B4AE-4A52-A831-7568D3877E0D</gtr:id><gtr:title>The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89054595f3e8c6d961598d722c9df7c5"><gtr:id>89054595f3e8c6d961598d722c9df7c5</gtr:id><gtr:otherNames>Moore C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>56e03662511d08.81941918</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A07F54F-F94C-4904-949B-D4B6D9BA34D7</gtr:id><gtr:title>Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35ac4d52038241a41c9817f6d48f885d"><gtr:id>35ac4d52038241a41c9817f6d48f885d</gtr:id><gtr:otherNames>C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>56e0340f29a4d4.40710189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31C6698D-120D-4BC3-83E7-E6340EA5F667</gtr:id><gtr:title>Association between walking speed and age in healthy, free-living individuals using mobile accelerometry--a cross-sectional study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc64af73d5d64b8d375c99cb214a187"><gtr:id>0fc64af73d5d64b8d375c99cb214a187</gtr:id><gtr:otherNames>Schimpl M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56e034109e2018.13146052</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>279E74B7-1E2D-4A4A-94B9-5E3877C89BD5</gtr:id><gtr:title>Recruitment and representativeness of blood donors in the INTERVAL randomised trial assessing varying inter-donation intervals.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89054595f3e8c6d961598d722c9df7c5"><gtr:id>89054595f3e8c6d961598d722c9df7c5</gtr:id><gtr:otherNames>Moore C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>585d3cff001bc7.40428409</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_qA137933</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>939798CA-B6AE-4C12-9DCC-A0F88F84E6F3</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Blood</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>90487A08-C473-4CEB-B6D9-011A74AD06CF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>8.4  Research design and methodologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>